van der Zee A G, Duk J M, Aalders J G, Boontje A H, ten Hoor K A, de Bruijn H W
Department of Obstetrics and Gynaecology, University Hospital of Groningen, The Netherlands.
Br J Obstet Gynaecol. 1990 Oct;97(10):934-8. doi: 10.1111/j.1471-0528.1990.tb02450.x.
The CA 125 assay is used to monitor the course of disease in women with adenocarcinoma of the genital tract. We measured serum CA 125 levels longitudinally in three different groups of patients who had normal serum CA 125 levels (less than or equal to 16 U/ml) before extensive intraperitoneal abdominal surgery (group 1, second-look laparotomy in 28 women with ovarian cancer; group 2, radical hysterectomy in 42 patients with cervical cancer; group 3, 13 men and one woman who had aortic surgery for atherosclerotic occlusive disease or aneurysm formation). Following surgery, rising serum CA 125 levels were observed in 69 out of the 84 patients (82%), irrespective of the primary diagnosis, type of operation or sex. The highest levels were found during the second week after the operation (range 3-336 U/ml) and decreased gradually thereafter, to become normal at 8 weeks after surgery. It was concluded that abdominal surgery interferes with the specificity of CA 125 as a tumour marker during the early postoperative period.
CA 125检测用于监测生殖道腺癌女性患者的病程。我们对三组不同患者的血清CA 125水平进行了纵向测量,这三组患者在广泛的腹腔内腹部手术前血清CA 125水平正常(小于或等于16 U/ml)(第1组,28例卵巢癌女性患者进行二次剖腹探查;第2组,42例宫颈癌患者进行根治性子宫切除术;第3组,13名男性和1名女性因动脉粥样硬化闭塞性疾病或动脉瘤形成接受主动脉手术)。手术后,84例患者中有69例(82%)血清CA 125水平升高,与原发诊断、手术类型或性别无关。最高水平出现在术后第二周(范围为3 - 336 U/ml),此后逐渐下降,术后8周恢复正常。得出的结论是,腹部手术在术后早期会干扰CA 125作为肿瘤标志物的特异性。